These lipid intermediates are associated with activation of stress and inflammatory pathways such as JNK and NF-κB, which have been observed in hepatocellular injury and more advanced histological stages of MASLD, including MASH. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.